PKPeter Herbert Kann

Peter Herbert Kann

*This is an algorithmically generated author record based on publicly available information.

Peter Herbert Kann has a total of 147 co-authors. Here are the top co-authors by number of shared publications:

  • Peyman Hadji

    Frankfurt Center of Bone Health and Endocrinology, Frankfurt Center of Bone Health and Endocrinology, Frankfurt am Main, Germany

    3 shared publications
  • S. Meyer

    3 shared publications
  • Simona Bergmann

    Centre for Endocrinology, Diabetology and Osteology, Endocrine Laboratory, Philipp’s University and University Hospital, Marburg

    3 shared publications
  • Simona Raluca Bergmann

    Division of Endocrinology & Diabetology, Philipp's University and University Hospital, Marburg, Hessia, Germany

    3 shared publications
  • A. Pfützner

    2 shared publications
  • Adrian Scheunemann

    Centre for Endocrinology, Diabetology and Osteology, Endocrine Laboratory, Philipp’s University and University Hospital, Marburg

    2 shared publications

Latest Publications

  • High-Resolution Peripheral Quantitative Computed Tomography (HR-pQCT) as a new Method for Human Osteoarcheology

    by Peter Herbert Kann, Tanja Pommerening, Rainer Brömer, Christopher John, Peyman Hadji

    In (pre)historic human bones, analysis of bone density and microstructure may be useful for anthropological research to assess skeletal health as well as physical fitness and handedness. Physical strain between arms and legs can be compared. HR-pQCT may provide information on such parameters, but has not yet been used in (pre)historic bones without soft tissue and bone marrow. Three macroscopically intact skeletons of young persons who died ca. 120–200 years ago at an age of approximately 20 years could be identified in the medico-historical anatomical collection in Marburg/Germany. Distal radii und tibiae were measured using HR-pQCT (XtremeCT, Scanco Medical) and analyzed with the standard evaluation script used for patients in clinical routine. We analyzed the quality of the images of the bones in comparison to two healthy living person of the same age group and investigated for which quantitative parameters plausible results could be calculated. The quality of the images was completely comparable between the historical bones and those of young living persons. Calculation of trabecular number, cortical thickness and cortical bone density revealed plausible results comparable to young living persons (77.5±26.9% vs. 84.4±28.3% of sex-related mean for persons 20–29 years old; n.s. [pooled data]). Calculation of trabecular bone volume / tissue volume and trabecular thickness, however, revealed unplausible results (−29.1±24.1% vs. 104.9±11.7; p<0.001). In conclusion, HR-pQCT generates images of historical bones in good quality. Calculation of trabecular number, cortical thickness, and cortical bone density reveals plausible results, whereas this is not the case for trabecular bone volume/tissue volume and trabecular thickness. This can be explained by the calculation method for these bone parameters, which is affected by the absence of soft tissue and bone marrow.

  • Abaloparatid – eine neue osteoanabole Therapieoption für die Osteoporose bei postmenopausalen Frauen

    by Peter Herbert Kann, Peyman Hadji, Andreas Kurth, Ralf Schmidmaier, Friederike Thomasius

    Zusammenfassung: Abaloparatid ist ein synthetisches Strukturanalogon des Parathormon-verwandten Peptids (PTHrP). Durch Bindung an Parathormon-1-Rezeptor stimuliert es Osteoblasten zum Knochenaufbau, dies bei einer geringeren begleitenden Osteoklastenstimulation, so dass in der Summe ein größerer osteoanaboler Nettoeffekt im Vergleich zu Teriparatid resultiert. Auch klinisch ist es mindestens so stark wirksam wie Teriparatid, möglicherweise diesem sogar überlegen, wobei hier unmittelbare head-to-head Studien derzeit nicht vorliegen. Abaloparatid reduziert effektiv das Auftreten vertebraler und peripherer osteoporotischer Frakturen mit auch entsprechenden günstigen Effekten auf die Knochendichte und die Knochenumbaumarker. Zu beachten ist, dass nach der subcutanen Injektion ein moderater Anstieg der Herzfrequenz beobachtet werden kann, wobei es aber keine Anhaltspunkte dafür gibt, dass dies mit schwerwiegenderen kardiovaskulären Komplikationen zu assoziieren wäre. Abaloparatid (Eladynos) wurde in Europa zur Behandlung der Osteoporose bei postmenopausalen Frauen mit erhöhtem Frakturrisiko für eine Therapiedauer von 18 Monaten zugelassen. Nachfolgend ist die Durchführung einer osteoklasteninhibierenden Bisphosphonattherapie als Sequenz zu empfehlen.


  • High-Resolution Peripheral Quantitative Computed Tomography (HR-pQCT) as a new Method for Human Osteoarcheology

    by Peter Herbert Kann, Tanja Pommerening, Rainer Brömer, Christopher John, Peyman Hadji

    Introduction: In (pre)historic human bones, analysis of bone density and microstructure may be useful for anthropological research to assess skeletal health as well as physical fitness and handedness. Physical strain between arms and legs can be compared. HR-pQCT may provide information on such parameters, but has not been used in (pre)historic bones without soft tissue and bone marrow yet. Methods: Three macroscopically intact skeletons of young persons who died 100-125 years ago at an age of approximately 20 years could be identified in the medical-historical-anatomical collection in Marburg/Germany. Distal radii und tibiae were measured using HR-pQCT (XtremeCT, Scanco Medical) and analyzed with the standard evaluation script used for patients in clinical routine. We analyzed (1) the quality of the pseudo-3D images of the bones in comparison to two healthy living person of the same age group and (2) proved for which quantitative parameters plausible results could be calculated. [Ethical votum: EK_MR_17_03_23_kann] Results: (1) The quality of the pseudo-3D images was completely comparable between the historical bones and those of young living persons. (2) Calculation of trabecular number, cortical thickness and cortical bone density revealed plausible results comparable to young living persons (77.5±26.9 % vs. 84.4±28.3 % of sex-related mean for persons 20 – 29 years old; n.s. [pooled data]). Calculation of trabecular bone volume/tissue volume and trabecular thickness, however, revealed unplausible results (-29.1±24.1 % vs. 104.9±11.7; p < 0.001). Discussion: In conclusion, HR-pQCT generates pseudo-3D images of historical bones in good quality. Calculation of trabecular number, cortical thickness and cortical bone density reveals plausible results, whereas this is not the case for trabecular bone volume/tissue volume and trabecular thickness. This can be explained by the calculation’s method of these bone parameters (Boutroy et al., J Clin Endocrinol 2005), which is affected by the absence of soft tissue and bone marrow. Keywords: paleoanthropology, bone densitometry, quantitative computed tomography Korrespondenzadresse: Peter Herbert Kann, Deutsches Endokrinologisches Versorgungszentrum, Düsseldorfer Str. 1-7, 60329 Frankfurt am Main, Deutschland, E-Mail: kannp@med.uni-marburg.de Article published online: 13 March 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag Rüdigerstraße 14, 70469 Stuttgart, Germany

  • Open Access

    Relevance of Endoscopic Ultrasound in Endocrinology Today: Multiple Endocrine Neoplasia Type 1, Insulinoma, Primary Aldosteronism—An Expert’s Perspective Based on Three Decades of Scientific and Clinical Experience

    by Peter Herbert Kann

    In endocrinology, endoscopic ultrasound (EUS) may be used to image the adrenals, the endocrine pancreas, and other organs where endocrine neoplasms may occur. During the recent decades, EUS has been established predominantly to assess multiple endocrine neoplasia type 1, to localize insulinomas, and to identify aldosterone-producing adenomas. EUS in endocrinology requires special skills and individual experience in order to provide reliable diagnostic information.


  • Regional Growth Velocity and Incidence of Pancreatic Neuroendocrine Neoplasias in Multiple Endocrine Neoplasia Type 1

    by Peter Herbert PhD Kann, Adrian Scheunemann, Jan Adelmeyer, Simona Bergmann, Joachim Nils Goebel, Detlef K. Bartsch, Katharina Holzer, Max B. Albers, Jerena Manoharan, Lisann M. Scheunemann

    Objectives: Pancreatic neuroendocrine neoplasias (pNENs) in multiple endocrine neoplasia type 1 are predominantly found in the dorsal anlage. Whether their growth velocity and incidence might be related to their location in the pancreas has not been investigated yet. Methods: We studied 117 patients using endoscopic ultrasound. Results: Growth velocity could be calculated for 389 pNENs. Increase of largest tumor diameter (% per month) was 0.67 (standard deviation [SD], 2.04) in the pancreatic tail (n = 138), 1.12 (SD, 3.00) in the pancreatic body (n = 100), 0.58 (SD, 1.19) in the pancreatic head/uncinate process—dorsal anlage (n = 130), and 0.68 (SD, 0.77) in the pancreatic head/uncinate process—ventral anlage (n = 12). Comparing growth velocity of all pNENs in the dorsal (n = 368, 0.76 [SD, 2.13]) versus ventral anlage, no significant difference was detected. Annual tumor incidence rate was 0.21 in the pancreatic tail, 0.13 in the pancreatic body, 0.17 in the pancreatic head/uncinate process—dorsal anlage, 0.51 dorsal anlage together, and 0.02 in the pancreatic head/uncinate process—ventral anlage. Conclusions: Multiple endocrine neoplasia type 1 pNENs are unequally distributed between ventral (low prevalence and incidence) and dorsal anlage. However, there are no regional differences in growth behavior.


  • Open Access

    Pancreaticoduodenectomy Is the Best Surgical Procedure for Zollinger–Ellison Syndrome Associated with Multiple Endocrine Neoplasia Type 1

    by Weihua Kong, Max Benjamin Albers, Jerena Manoharan, Joachim Nils Goebel, Peter Herbert Kann, Moritz Jesinghaus, Detlef Klaus Bartsch

    Aim: The aim of this research was to evaluate the long-term outcome of pancreaticoduodenectomy (PD) versus other duodenopancreatic resections (non-PD) for the surgical treatment of the Zollinger–Ellison syndrome (ZES) in patients with multiple endocrine neoplasia type 1 (MEN1). Methods: Prospectively recorded patients with biochemically confirmed MEN1-ZES who underwent duodenopancreatic surgery were retrospectively analyzed in terms of clinical characteristics, complications, cure rate, and long-term morbidity, including quality of life assessment (EORTC QLQ-C30). Results: 35 patients (16 female, 19 male) with MEN1-ZES due to duodenopancreatic gastrinomas with a median age of 42 (range 30–74) years were included. At the time of diagnosis, 28 (80%) gastrinomas were malignant, but distant metastases were only present in one (3%) patient. Eleven patients (31.4%) underwent pancreatoduodenectomy (PD) as the initial procedure, whereas 24 patients underwent non-PD resections involving duodenotomy with gastrinoma excision, enucleation of the pNEN from the head of the pancreas, and peripancreatic lymphadenectomy, either with or without distal pancreatectomy (i.e., either Thompson procedure, n = 12, or DUODX, n = 12). There was no significant difference in perioperative morbidity and mortality between the two groups (p ≥ 0.05). One (9%) patient of the PD group required reoperation for recurrent or metastatic ZES compared to eight (22.8%) patients of the non-PD resection groups. After a median follow-up time of 134 months (range 6–480) nine of 11 (82%) patients in the PD group, two of 12 (16%) patients in the Thompson procedure group, and three of 12 (25%) patients in the DUODX group had normal serum gastrin levels. In addition, the global health QoLScore was better in the PD group (76.9) compared to the Thompson procedure (57.4) and DUODX (59.5) groups. Conclusions: Initial PD seems to be the superior surgical procedure for MEN1-ZES, resulting in a long-term cure rate of about 80%, fewer duodenopancreatic reoperations, and an acceptable quality of life.


  • Pancreatic Neuroendocrine Neoplasias in Multiple Endocrine Neoplasia Type 1 Are Predominantly Located in the Dorsal Anlage

    by Peter Herbert PhD Kann, Adrian Scheunemann, Peter Dorzweiler, Jan Adelmeyer, Simona Bergmann, Joachim Nils Goebel, Verena Mann, Detlef K. Bartsch, Katharina Holzer, Max B. Albers, et al.

    Objectives: Pancreatic neuroendocrine neoplasias (pNENs) frequently occur in multiple endocrine neoplasia type 1 (MEN1). Their distribution referring to embryology, that is, the pancreatic anlagen, has not been investigated yet. Methods: In the time between 1998 and 2019, we studied the distribution of pNENs in MEN1 concerning the embryologic origin of the pancreas, that is, the dorsal versus ventral anlage using endoscopic ultrasound in 117 MEN1 patients: 56 women, 61 men; aged 40 years (standard deviation, 14 years) at first endoscopic ultrasound. Results: In 105 patients, a total of 628 pNENs were detected. They were located in the pancreatic tail: 231; pancreatic body: 177; pancreatic head/uncinate process: 220. Of the latter, 22 were located in the ventral anlage, 176 in the dorsal anlage, and 22 remained undefined. In summary, just 3.5% of all detected pNENs were located in the ventral anlage, 93.0% in the dorsal anlage, and 3.5% could not be assigned. Conclusions: Our study indicates that the vast majority of pNENs in MEN1 is located in the dorsal anlage, whereas the ventral anlage of the pancreas seems to be to a large extend spared from pNENs. Implications for new surgical strategies might be considered.